Abstract
Parkinson’s disease (PD) is the second most common age-related neurodegenerative disorders of the central nervous system, which mainly impairs the motor system. However, the pathogenic mechanisms are still unclear. Gene–environment complex interaction leads to selective dopaminergic neuron death in PD. Growing evidences supports that neuroinflammatory responses are involved in the pathogenesis of PD. This review critically discusses current studies on the inflammatory response of the pathological process of PD. The mechanisms and strategies of modifying inflammatory responses would be potential treatments for neurodegenerative diseases.
Similar content being viewed by others
References
Alvarez JI, Katayama T, Prat A (2013) Glial influence on the blood brain barrier. GLIA 61:1939–1958
Aron L, Klein R (2011) Repairing the parkinsonian brain with neurotrophic factors. Trends Neurosci 34:88–100
Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E (2009) Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183:787–791
Braak H, Del TK, Rub U, de Vos RA, Jansen SE, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197–211
Butovsky O, Weiner HL (2018) Microglial signatures and their role in health and disease. Nat Rev Neurosci 19:622–635
Calabrese V, Santoro A, Monti D, Crupi R, di Paola R, Latteri S, Cuzzocrea S, Zappia M, Giordano J, Calabrese EJ, Franceschi C (2018) Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol Med 115:80–91
Cao B, Wang T, Qu Q, Kang T, Yang Q (2018) Long noncoding RNA SNHG1 promotes Neuroinflammation in Parkinson's Disease via regulating miR-7/NLRP3 pathway. Neuroscience 388:118–127
Chaudhuri KR, Todorova A, Nirenberg MJ, Parry M, Martin A, Martinez-Martin P, Rizos A, Henriksen T, Jost W, Storch A, Ebersbach G, Reichmann H, Odin P, Antonini A (2015) A pilot prospective, multicenter observational study of dopamine agonist withdrawal syndrome in Parkinson's disease. Mov Disord Clin Pract 2:170–174
Chen J, Ren Y, Gui C, Zhao M, Wu X, Mao K, Li W, Zou F (2018) Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T alpha-synuclein model of Parkinson's disease. Cell Death Dis 9:700
Choi DJ, Eun JH, Kim BG, Jou I, Park SM, Joe EH (2018) A Parkinson's disease gene, DJ-1, repairs brain injury through Sox9 stabilization and astrogliosis. GLIA 66:445–458
Choi DJ, Yang H, Gaire S, Lee KA, An J, Kim BG, Jou I, Park SM, Joe EH (2020) Critical roles of astrocytic-CCL2-dependent monocyte infiltration in a DJ-1 knockout mouse model of delayed brain repair. GLIA. https://doi.org/10.1002/glia.23828
Comi C, Cosentino M, Pacheco R (2019) Editorial: peripheral immunity in Parkinson's Disease: emerging role and novel target for therapeutics. Front Neurol 10:1080
Davie CA (2008) A review of Parkinson's disease. Br Med Bull 86:109–127
De Luca C, Colangelo AM, Alberghina L, Papa M (2018) Neuro-immune hemostasis: homeostasis and diseases in the central nervous system. Front Cell Neurosci 12:459
De Miranda BR, Rocha EM, Bai Q et al (2018) Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease. Neurobiol Dis 115:101–114
Desai BB, Patel A, Schneider JA, Carvey PM, Hendey B (2012) Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy. J Neural Transm (Vienna) 119:59–71
di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Muñoz JP, Richaud-Patin Y, Fernandez-Carasa I, Gut M, Faella A, Parameswaran J, Soriano J, Ferrer I, Tolosa E, Zorzano A, Cuervo AM, Raya A, Consiglio A (2019) Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous Neurodegeneration in Parkinson's Disease. Stem Cell Rep 12:213–229
Diniz LP, Matias I, Araujo A et al (2019) Alpha-synuclein oligomers enhance astrocyte-induced synapse formation through TGF-beta1 signaling in a Parkinson's disease model. J Neurochem 150:138–157
Dorf ME, Berman MA, Tanabe S, Heesen M, Luo Y (2000) Astrocytes express functional chemokine receptors. J Neuroimmunol 111:109–121
Drouin-Ouellet J, St-Amour I, Saint-Pierre M et al (2014) Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson’s disease. Int J Neuropsychopharmacol 18(6):1–11
Ebrahimi-Fakhari D, Wahlster L, McLean PJ (2012) Protein degradation pathways in Parkinson’s disease: curse or blessing. Acta Neuropathol 124:153–172
Fan Z, Lu M, Qiao C, Zhou Y, Ding JH, Hu G (2016) MicroRNA-7 enhances subventricular zone neurogenesis by inhibiting NLRP3/Caspase-1 Axis in adult Neural stem cells. Mol Neurobiol 53:7057–7069
Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, Lautrup S, Hasan-Olive MM, Caponio D, Dan X, Rocktäschel P, Croteau DL, Akbari M, Greig NH, Fladby T, Nilsen H, Cader MZ, Mattson MP, Tavernarakis N, Bohr VA (2019) Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. Nat Neurosci 22:401–412
Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, Wenning GK, Stefanova N (2013) Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia. GLIA 61:349–360
Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ, Ladner KJ, Bevan AK, Foust KD, Godbout JP, Popovich PG, Guttridge DC, Kaspar BK (2014) Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron 81:1009–1023
Fricke IB, Viel T, Worlitzer MM, Collmann FM, Vrachimis A, Faust A, Wachsmuth L, Faber C, Dollé F, Kuhlmann MT, Schäfers K, Hermann S, Schwamborn JC, Jacobs AH (2016) 6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis. Eur J Neurosci 43:1352–1365
Giridharan VV, Reus GZ, Selvaraj S, Scaini G, Barichello T, Quevedo J (2019) Maternal deprivation increases microglial activation and neuroinflammatory markers in the prefrontal cortex and hippocampus of infant rats. J Psychiatr Res 115:13–20
Gordon R, Albornoz EA, Christie DC et al (2018) Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med 10(465):1–12
Gui C, Ren Y, Chen J, Wu X, Mao K, Li H, Yu H, Zou F, Li W (2020) p38 MAPK-DRP1 signaling is involved in mitochondrial dysfunction and cell death in mutant A53T alpha-synuclein model of Parkinson's disease. Toxicol Appl Pharmacol 388:114874
Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132:344–362
Heid ME, Keyel PA, Kamga C, Shiva S, Watkins SC, Salter RD (2013) Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J Immunol 191:5230–5238
Herrera-Ruiz M, Jimenez-Ferrer E, Tortoriello J et al (2019) Anti-neuroinflammatory effect of agaves and cantalasaponin-1 in a model of LPS-induced damage. Nat Prod Res 14:1–4
Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, Cass WA, Sullivan PG, Bing G (2007) Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. J Neurochem 100:1375–1386
Jankovic J (2008) Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368–376
Joshi N, Singh S (2018) Updates on immunity and inflammation in Parkinson disease pathology. J Neurosci Res 96:379–390
Julian MW, Shao G, Bao S, Knoell DL, Papenfuss TL, VanGundy ZC, Crouser ED (2012) Mitochondrial transcription factor a serves as a danger signal by augmenting plasmacytoid dendritic cell responses to DNA. J Immunol 189:433–443
Kabaria S, Choi DC, Chaudhuri AD, Mouradian MM, Junn E (2015) Inhibition of miR-34b and miR-34c enhances alpha-synuclein expression in Parkinson's disease. FEBS Lett 589:319–325
Kalia LV, Lang AE (2015) Parkinson's disease. Lancet 386:896–912
Kannarkat GT, Boss JM, Tansey MG (2013) The role of innate and adaptive immunity in Parkinson's disease. J Park Dis 3:493–514
Kanthasamy A, Jin H, Charli A, Vellareddy A, Kanthasamy A (2019) Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms. Pharmacol Ther 197:61–82
Kempuraj D, Ahmed ME and Selvakumar GP, et al (2019) Brain injury-mediated Neuroinflammatory response and Alzheimer’s Disease. Neuroscientist 26(2):134–155
Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, Joong Lee S, Masliah E, Hwang D, Lee HJ, Lee SJ (2013) Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun 4:1562
Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, Shen C, Lee H, Kulkarni S, Pasricha PJ, Lee G, Pomper MG, Dawson VL, Dawson TM, Ko HS (2019) Transneuronal propagation of pathologic alpha-Synuclein from the gut to the brain models Parkinson's Disease. Neuron 103:627–641
Kong H, Yang L, He C, Zhou JW, Li WZ, Wu WN, Chen HQ, Yin YY (2019) Chronic unpredictable mild stress accelerates lipopolysaccharide- induced microglia activation and damage of dopaminergic neurons in rats. Pharmacol Biochem Behav 179:142–149
Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Minafra B, Riboldazzi G, Sturchio A, Mauri M, Bono G, Marino F, Cosentino M (2018) Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naive and drug-treated patients. J Neuroinflammation 15:205
Lacy M, Jones J, Whittemore SR, Haviland DL, Wetsel RA, Barnum SR (1995) Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J Neuroimmunol 61:71–78
Larsen SB, Hanss Z, Kruger R (2018) The genetic architecture of mitochondrial dysfunction in Parkinson's disease. Cell Tissue Res 373:21–37
Lee E, Hwang I, Park S et al (2018) MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ 26(2):213–228
Lee Y, Lee S, Chang SC, Lee J (2019) Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention. Arch Pharm Res 42:416–425
Li D, Yang H, Ma J, Luo S, Chen S, Gu Q (2018) MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3. Hum Cell 31:106–115
Lim S, Kim HJ, Kim DK, Lee SJ (2018) Non-cell-autonomous actions of alpha-synuclein: implications in glial synucleinopathies. Prog Neurobiol 169:158–171
Liu Z, Huang Y, Cao BB, Qiu YH, Peng YP (2017) Th17 cells induce dopaminergic neuronal death via LFA-1/ICAM-1 interaction in a mouse model of Parkinson's Disease. Mol Neurobiol 54:7762–7776
Liu Q, Guo X, Huang Z et al (2020) Anti-neuroinflammatory effects of dimethylaminomylide (DMAMCL, i.e., ACT001) are associated with attenuating the NLRP3 in fl ammasome in MPTP-induced Parkinson disease in mice. Behav Brain Res 383:112539
Loria F, Vargas JY, Bousset L, Syan S, Salles A, Melki R, Zurzolo C (2017) Alpha-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading. Acta Neuropathol 134:789–808
Luo J, Padhi P, Jin H, Anantharam V, Zenitsky G, Wang Q, Willette AA, Kanthasamy A, Kanthasamy AG (2019) Utilization of the CRISPR-Cas9 gene editing system to dissect Neuroinflammatory and Neuropharmacological mechanisms in Parkinson's Disease. J NeuroImmune Pharmacol 14:595–607
Marchetti B (2018) Wnt/beta-Catenin signaling pathway governs a full program for dopaminergic neuron survival, neurorescue and regeneration in the MPTP mouse model of Parkinson's disease. Int J Mol Sci 19(12):3743
Marchetti B, Serra PA, Tirolo C, L'Episcopo F, Caniglia S, Gennuso F, Testa N, Miele E, Desole S, Barden N, Morale MC (2005) Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions. Brain Res Brain Res Rev 48:302–321
McCann MJ, O'Callaghan JP, Martin PM, Bertram T, Streit WJ (1996) Differential activation of microglia and astrocytes following trimethyl tin-induced neurodegeneration. Neuroscience 72:273–281
McGregor MJ, Cohen M, Stocks-Rankin CR et al (2011) Complaints in for-profit, non-profit and public nursing homes in two Canadian provinces. Open Med 5:e183–e192
Mettang M, Reichel SN, Lattke M, Palmer A, Abaei A, Rasche V, Huber-Lang M, Baumann B, Wirth T (2018) IKK2/NF-kappaB signaling protects neurons after traumatic brain injury. FASEB J 32:1916–1932
Minton K (2016) Inflammasome: anti-inflammatory effect of mitophagy. Nat Rev Immunol 16:206
Munoz MF, Arguelles S, Medina R, Cano M, Ayala A (2019) Adipose-derived stem cells decreased microglia activation and protected dopaminergic loss in rat lipopolysaccharide model. J Cell Physiol
Nakamura M, Okada S, Toyama Y, Okano H (2005) Role of IL-6 in spinal cord injury in a mouse model. Clin Rev Allergy Immunol 28:197–204
Narayan S, Liew Z, Bronstein JM, Ritz B (2017) Occupational pesticide use and Parkinson's disease in the Parkinson environment gene (PEG) study. Environ Int 107:266–273
Osakada F, Ooto S, Akagi T, Mandai M, Akaike A, Takahashi M (2007) Wnt signaling promotes regeneration in the retina of adult mammals. J Neurosci 27:4210–4219
Parkinson's Disease (2018) Pathogenesis and clinical aspects. Codon Publications, Brisbane (AU)
Poly TN, Islam M, Yang HC, Li YJ (2019) Non-steroidal anti-inflammatory drugs and risk of Parkinson's disease in the elderly population: a meta-analysis. Eur J Clin Pharmacol 75:99–108
Ren Y, Chen J, Wu X, Gui C, Mao K, Zou F, Li W (2018) Role of c-Abl-GSK3beta signaling in MPP+-induced autophagy-Lysosomal dysfunction. Toxicol Sci 165:232–243
Sanyal A, DeAndrade MP, Novis HS et al (2020) Lysosome and inflammatory defects in GBA1-mutant astrocytes are normalized by LRRK2 inhibition. Mov Disord 35:760–773
Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, di Malta C, Donaudy F, Embrione V, Polishchuk RS, Banfi S, Parenti G, Cattaneo E, Ballabio A (2009) A gene network regulating lysosomal biogenesis and function. SCIENCE 325:473–477
Shabab T, Khanabdali R, Moghadamtousi SZ, Kadir HA, Mohan G (2017) Neuroinflammation pathways: a general review. Int J Neurosci 127:624–633
Shen Y, Sun A, Wang Y, Cha D, Wang H, Wang F, Feng L, Fang S, Shen Y (2012) Upregulation of mesencephalic astrocyte-derived neurotrophic factor in glial cells is associated with ischemia-induced glial activation. J Neuroinflammation 9:254
Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA, Sher A, Kehrl JH (2012) Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 13:255–263
Sierra A, Denes A (2019) Editorial for the special issue: microglia-neuron interactions in health and disease - novel perspectives for translational research. Neuroscience 405:1–2
Sliter DA, Martinez J, Hao L, Chen X, Sun N, Fischer TD, Burman JL, Li Y, Zhang Z, Narendra DP, Cai H, Borsche M, Klein C, Youle RJ (2018) Parkin and PINK1 mitigate STING-induced inflammation. Nature 561:258–262
Sommer A, Maxreiter F, Krach F et al (2018) Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson's Disease. Cell Stem Cell 23:123–131
Sun C, Yu W, Zhao Z, Song C, Liu Y, Jia G, Wang X, Liu Y (2019) Peripheral Humoral immune response is associated with the non-motor symptoms of Parkinson's Disease. Front Neurosci 13:1057
Tarakad A, Jankovic J (2017) Diagnosis and Management of Parkinson's Disease. Semin Neurol 37:118–126
Tsutsumi R, Hori Y, Seki T, Kurauchi Y, Sato M, Oshima M, Hisatsune A, Katsuki H (2019) Involvement of exosomes in dopaminergic neurodegeneration by microglial activation in midbrain slice cultures. Biochem Biophys Res Commun 511:427–433
Udovin L, Quarracino C, Herrera MI, Capani F, Otero-Losada M, Perez-Lloret S (2020) Role of Astrocytic dysfunction in the pathogenesis of Parkinson's Disease animal models from a molecular signaling perspective. Neural Plast 2020:1859431
van der Brug MP, Singleton A, Gasser T, Lewis PA (2015) Parkinson's disease: from human genetics to clinical trials. Sci Transl Med 7:205p–220p
Wilkins HM, Carl SM, Greenlief AC, Festoff BW, Swerdlow RH (2014) Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection. Front Aging Neurosci 6:311
Wilkins HM, Carl SM, Weber SG, Ramanujan SA, Festoff BW, Linseman DA, Swerdlow RH (2015) Mitochondrial lysates induce inflammation and Alzheimer's disease-relevant changes in microglial and neuronal cells. J Alzheimers Dis 45:305–318
Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, Zhou R (2015) Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 160:62–73
Yu SY, Zuo LJ, Wang F, Chen ZJ, Hu Y, Wang YJ, Wang XM, Zhang W (2014) Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: a cross-sectional study. BMC Neurol 14:113
Yun SP, Kam TI, Panicker N, Kim SM, Oh Y, Park JS, Kwon SH, Park YJ, Karuppagounder SS, Park H, Kim S, Oh N, Kim NA, Lee S, Brahmachari S, Mao X, Lee JH, Kumar M, An D, Kang SU, Lee Y, Lee KC, Na DH, Kim D, Lee SH, Roschke VV, Liddelow SA, Mari Z, Barres BA, Dawson VL, Lee S, Dawson TM, Ko HS (2018) Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease. Nat Med 24:931–938
Zahoor I, Shafi A, Haq E (2018) Pharmacological treatment of Parkinson’s disease: a Review. JAMA 311(16):1670–1683
Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469:221–225
Zhou Y, Lu M, Du RH et al (2016) MicroRNA-7 targets nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease. Mol Neurodegener 11:28
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yang, L., Mao, K., Yu, H. et al. Neuroinflammatory Responses and Parkinson’ Disease: Pathogenic Mechanisms and Therapeutic Targets. J Neuroimmune Pharmacol 15, 830–837 (2020). https://doi.org/10.1007/s11481-020-09926-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-020-09926-7